Detalhe da pesquisa
1.
Functional genomic landscape of acute myeloid leukaemia.
Nature
; 562(7728): 526-531, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30333627
2.
Genomic landscape of neutrophilic leukemias of ambiguous diagnosis.
Blood
; 134(11): 867-879, 2019 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31366621
3.
Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies.
Proc Natl Acad Sci U S A
; 114(36): E7554-E7563, 2017 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28784769
4.
Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemia.
Cold Spring Harb Mol Case Stud
; 8(6)2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36307214
5.
Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia.
J Clin Oncol
; 38(10): 1006-1018, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31880950
6.
Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms.
Nat Commun
; 10(1): 244, 2019 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30651561
7.
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma.
Cancer Res
; 77(23): 6614-6626, 2017 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28951465
8.
The Colony-Stimulating Factor 3 Receptor T640N Mutation Is Oncogenic, Sensitive to JAK Inhibition, and Mimics T618I.
Clin Cancer Res
; 22(3): 757-64, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26475333
9.
IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms.
Oncotarget
; 7(6): 6948-59, 2016 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-26755644